236 related articles for article (PubMed ID: 26890063)
21. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
[TBL] [Abstract][Full Text] [Related]
22. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
23. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
24. The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.
Alaaeddine N; Antoniou J; Moussa M; Hilal G; Kreichaty G; Ghanem I; Abouchedid W; Saghbini E; Di Battista JA
Inflamm Res; 2015 Sep; 64(9):721-31. PubMed ID: 26189947
[TBL] [Abstract][Full Text] [Related]
25. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
[TBL] [Abstract][Full Text] [Related]
26. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
27. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
[TBL] [Abstract][Full Text] [Related]
28. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
29. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
30. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
31. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
32. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
[TBL] [Abstract][Full Text] [Related]
33. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
34. Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.
Iwamoto R; Takahashi T; Yoshimi K; Imai Y; Koide T; Hara M; Ninomiya T; Nakamura H; Sayama K; Yukita A
J Bone Miner Metab; 2021 Jul; 39(4):558-571. PubMed ID: 33721112
[TBL] [Abstract][Full Text] [Related]
35. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
36. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.
Skovdahl HK; Damås JK; Granlund AVB; Østvik AE; Doseth B; Bruland T; Mollnes TE; Sandvik AK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347808
[TBL] [Abstract][Full Text] [Related]
37. CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies.
Das M; Tang X; Han JY; Mayilsamy K; Foran E; Biswal MR; Tzekov R; Mohapatra SS; Mohapatra S
J Neuroinflammation; 2019 May; 16(1):115. PubMed ID: 31151410
[TBL] [Abstract][Full Text] [Related]
38. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.
Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Graeber S; Sperling J; Kollmar O; Schilling MK
World J Gastroenterol; 2011 Jul; 17(26):3109-16. PubMed ID: 21912453
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20.
Wasilko DJ; Johnson ZL; Ammirati M; Che Y; Griffor MC; Han S; Wu H
Nat Commun; 2020 Jun; 11(1):3031. PubMed ID: 32541785
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
